generation of hematopoietic progenitor cells
The generation of hematopoietic progenitor cells from induced pluripotent stem cells (iPSCs) provides a scalable and patient-specific approach for blood cell development, regenerative medicine, and disease modeling. Unlike traditional hematopoietic stem cells (HSCs), iPSC-derived HPCs bypass donor limitations and immunogenic concerns.
